Literature DB >> 11925274

Provisional diagnostic criteria for depression of Alzheimer disease: rationale and background.

Jason T Olin1, Ira R Katz, Barnett S Meyers, Lon S Schneider, Barry D Lebowitz.   

Abstract

This review provides the rationale and background for the development of diagnostic criteria for depression of Alzheimer disease (AD), including risk factors and neurobiological correlates, epidemiology, and clinical characteristics, along with course, assessment, treatment, economics, a description of the criteria, and future research directions. Overall, there is substantial research to suggest that the depression that may co-occur with AD is different from other depressive disorders. Further research is needed to better define core symptoms, clinical course, and efficacy of treatments.

Entities:  

Mesh:

Year:  2002        PMID: 11925274

Source DB:  PubMed          Journal:  Am J Geriatr Psychiatry        ISSN: 1064-7481            Impact factor:   4.105


  50 in total

1.  Measuring symptoms of depression: comparing the Cornell Scale for Depression in Dementia and the Patient Health Questionnaire-9-Observation Version.

Authors:  Lorraine J Phillips
Journal:  Res Gerontol Nurs       Date:  2011-12-14       Impact factor: 1.571

2.  Reduced benefit from mnemonic strategies in early-stage Alzheimer's disease: a brief testing-the-limits paradigm for clinical practice.

Authors:  Ingo Uttner; Niklas Schurig; Christine A F von Arnim; Christian Lange-Asschenfeldt; Hayrettin Tumani; Matthias W Riepe
Journal:  J Neurol       Date:  2010-06-11       Impact factor: 4.849

3.  Incidence and predictive factors of depressive symptoms in Alzheimer's disease: the REAL.FR study.

Authors:  C Arbus; V Gardette; C E Cantet; S Andrieu; F Nourhashémi; L Schmitt; B Vellas
Journal:  J Nutr Health Aging       Date:  2011-08       Impact factor: 4.075

4.  Neuropsychiatric symptoms in MCI subtypes: the importance of executive dysfunction.

Authors:  Paul B Rosenberg; Michelle M Mielke; Brian Appleby; Esther Oh; Jeannie-Marie Leoutsakos; Constantine G Lyketsos
Journal:  Int J Geriatr Psychiatry       Date:  2010-09-15       Impact factor: 3.485

5.  Do treatment effects vary among differing baseline depression criteria in depression in Alzheimer's disease study ± 2 (DIADS-2)?

Authors:  Lea T Drye; Barbara K Martin; Constantine E Frangakis; Curtis L Meinert; Jacobo E Mintzer; Cynthia A Munro; Anton P Porsteinsson; Peter V Rabins; Paul B Rosenberg; Lon S Schneider; Daniel Weintraub; Constantine G Lyketsos
Journal:  Int J Geriatr Psychiatry       Date:  2011-06       Impact factor: 3.485

6.  Impact of White Matter Lesions on Depression in the Patients with Alzheimer's Disease.

Authors:  Jung Jae Lee; Eun Young Lee; Seok Bum Lee; Joon Hyuk Park; Tae Hui Kim; Hyun-Ghang Jeong; Jae Hyoung Kim; Ji Won Han; Ki Woong Kim
Journal:  Psychiatry Investig       Date:  2015-09-30       Impact factor: 2.505

Review 7.  A practical approach to detection and treatment of depression in Parkinson disease and dementia.

Authors:  Zahra Goodarzi; Zahinoor Ismail
Journal:  Neurol Clin Pract       Date:  2017-04

Review 8.  Detection of depression in older adults with dementia.

Authors:  Ellen L Brown; Patrick Raue; Karen D Halpert; Susan Adams; Marita G Titler
Journal:  J Gerontol Nurs       Date:  2009-02       Impact factor: 1.254

9.  Sertraline for the treatment of depression in Alzheimer disease.

Authors:  Paul B Rosenberg; Lea T Drye; Barbara K Martin; Constantine Frangakis; Jacobo E Mintzer; Daniel Weintraub; Anton P Porsteinsson; Lon S Schneider; Peter V Rabins; Cynthia A Munro; Curtis L Meinert; Constantine G Lyketsos
Journal:  Am J Geriatr Psychiatry       Date:  2010-02       Impact factor: 4.105

10.  Sertraline for the treatment of depression in Alzheimer disease: week-24 outcomes.

Authors:  Daniel Weintraub; Paul B Rosenberg; Lea T Drye; Barbara K Martin; Constantine Frangakis; Jacobo E Mintzer; Anton P Porsteinsson; Lon S Schneider; Peter V Rabins; Cynthia A Munro; Curtis L Meinert; Constantine G Lyketsos
Journal:  Am J Geriatr Psychiatry       Date:  2010-04       Impact factor: 4.105

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.